SCHEMBL7051955

SCHEMBL7051955

CCOC(=O)CC1CCN(C2CCCC[N]2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 3/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
THRB P10828 1/20 0.34
ATM Q13315 1/20 0.34
PARP14 Q460N5 1/20 0.34
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
KCNH2 Q12809 1/20 0.33
GRIN2B Q13224 1/20 0.33
CYP2D6 P10635 1/20 0.33
MEN1 O00255 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052823 0.87 KMT2A (0.38) POLBKMT2AALDH1A1TDP1L3MBTL1
SCHEMBL7052120 0.80 FFAR4 (0.34) OPRM1OPRD1OPRK1OGFRL1
SCHEMBL14809700 0.77 POLB (0.46) POLBKMT2AALDH1A1TDP1KCNH2
SCHEMBL15600402 0.76 CHRM1 (0.48) POLBALDH1A1TDP1PARP14GAA
SCHEMBL18595476 0.76 POLB (0.40) POLBKMT2AALDH1A1TDP1L3MBTL1
SCHEMBL1439129 0.75 TDP1 (0.48) POLBKMT2AALDH1A1TDP1L3MBTL1
SCHEMBL7051959 0.75 POLB (0.41) POLBKMT2AALDH1A1TDP1L3MBTL1
SCHEMBL25311355 0.74 TDP1 (0.50) POLBKMT2AALDH1A1TDP1L3MBTL1
SCHEMBL18797 0.74 TDP1 (0.50) POLBKMT2AALDH1A1TDP1L3MBTL1
SCHEMBL2779505 0.74 TDP1 (0.50) POLBKMT2AALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171361-A1 Pyrrolopyrimidinone derivatives, process of preparation and use SK CHEMICALS CO., LTD. (KR) 2003-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171361-A1 Pyrrolopyrimidinone derivatives, process of preparation and use CYP2C19, DHPS, SDHA POLB 498/4885KMT2A 4373/4885ALDH1A1 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.